The course of anticardiolipin antibody levels under immunoadsorption therapy

American Journal of Kidney Diseases

Volumn 46, Issue 3, 2005, Pages 446-454

  Hauser, Anna Christine ^a   Hauser, Lorenz ^b   Pabinger Fasching, Ingrid ^b   Quehenberger, Peter ^b   Derfler, Kurt ^b   Hörl, Walter Hermann ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Anticardiolipin antibodies; Fetal loss; Immunoadsorption; Renal insufficiency; Systemic lupus erythematosus (SLE)

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; HEMOCONCENTRATION; HUMAN; IMMUNOADSORPTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LONG TERM CARE; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BLOOD COMPONENT REMOVAL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, MULTIPLE; PROTEINURIA; THROMBOPHILIA; TREATMENT OUTCOME; TWINS;

EID: 23944461783     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.05.023     Document Type: Article

References (41)

1. J.S. Levine, D.W. Branch, J. Rauch The antiphospholipid syndrome N Engl J Med 346 2002 752 763
2. F. Fakhouri, L.H. Noel, J. Zuber The expanding spectrum of renal diseases associated with antiphospholipid syndrome Am J Kidney Dis 41 2003 1205 1211
3. M. Petri Epidemiology of the antiphospholipid antibody syndrome J Autoimmun 15 2000 145 151
4. S.R. Levine, R.L. Brey, B.C. Tilley APASS Investigators Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke JAMA 291 2004 576 584
5. J. Chapman, J.H. Rand, R.L. Brey Non-stroke neurological syndromes associated with antiphospholipid antibodies Evaluation of clinical and experimental studies Lupus 12 2003 514 517
6. R.L. Brey, J. Chapman, S.R. Levine Stroke and the antiphospholipid syndrome Consensus meeting Taormina 2002 Lupus 12 2003 508 513
7. M. Petri The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis) Hopkins Lupus Cohort Thromb Res 114 2004 593 595
8. M. Lockshin, F. Tenedios, M. Petri Cardiac disease in the antiphospholipid syndrome Recommendations for treatment Committee consensus report. Lupus 12 2003 518 523
9. G. Moroni, D. Ventura, P. Riva Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis Am J Kidney Dis 43 2004 28 36
10. R.A. Asherson, R. Cervera, J.C. Piette Catastrophic antiphospholipid syndrome Clues to the pathogenesis from a series of 80 patients Medicine (Baltimore) 80 2001 355 377
11. M. Haas, N. Mayr, J. Zeitlhofer, A. Goldammer, K. Derfler Long-term treatment of myasthenia gravis with immunoadsorption J Clin Apheresis 17 2002 84 87
12. A. Goldammer, K. Derfler, K. Herkner, A.R. Bradwell, W.H. Hörl, M. Haas Influence of plasma immunoglobulin level on antibody synthesis Blood 100 2002 353 355
13. S. Schmaldienst, M. Jansen, U. Hollenstein Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis Am J Kidney Dis 39 2002 415 418
14. S. Schmaldienst, A. Goldammer, S. Spitzauer, K. Derfler, W.H. Hörl, P. Knöbl Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption Am J Kidney Dis 36 2000 490 497
15. K. Laczika, S. Knapp, K. Derfler, A. Soleiman, W.H. Hörl, W. Druml Immunoadsorption in Goodpasture's syndrome Am J Kidney Dis 36 2000 392 395
16. M. Jansen, S. Schmaldienst, S. Banyai Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb) Br J Haematol 112 2001 91 97
17. A. Staudt, M. Böhm, F. Knebel Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy Circulation 106 2002 2448 2453
18. M. Böhm, T. Dörner, F. Knebel, A. Bruns, N. Jochmann, G. Baumann Longlasting effects of immunoadsorption in severe Sjogren's syndrome Ann Rheum Dis 63 2004 214 215
19. W. Rabitsch, P. Knoebl, H. Greinix Removal of persisting isohaemagglutinins with Ig-Therasorb immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation Nephrol Dial Transplant 18 2003 2405 2408
20. E.M. Tan, A.S. Cohen, J.F. Fries The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1982 1271 1277
21. M. Petri, L. Magder Classification criteria for systemic lupus erythematosus A review Lupus 13 2004 829 837
22. G.H. Stummvoll, M. Aringer, J.S. Smolen IgG immunoadsorption (IAS) reduces SLE activity and proteinuria - A long term observational study Ann Rheum Dis 64 2005 1015 1021
23. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
24. P. Alba, L. Bento, M.J. Cuadrado Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant Significant factors associated with lupus nephritis Ann Rheum Dis 62 2003 556 560
25. M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, G.R. Hughes The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
26. R.A. Asherson, R. Cervera, P.G. de Groot Catastrophic Antiphospholipid Syndrome Registry Project Group: Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines Lupus 12 2003 530 534
27. N. Braun, S. Gutenberger, C.M. Erley, T. Risler Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A Sepharose Transfus Sci 19 1998 S25 S31 (suppl 1)
28. S. Schmaldienst, M. Muellner, A. Goldammer Intravenous immunoglobulin application following immunoadsorption Benefit or risk in patients with autoimmune diseases? Rheumatology 40 2001 513 521
29. R.E. Joseph, J. Radhakrishnan, G.B. Appel Antiphospholipid antibody syndrome and renal disease Curr Opin Nephrol Hypertens 10 2001 175 181
30. M. Galli, D. Luciani, G. Bertolini, T. Barbui Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome Blood 102 2003 2717 2723
31. A.C. Hauser, I. Pabinger-Fasching, P. Quehenberger, J. Kettenbach, W.H. Hörl A patient with sudden abdominal pain 10 years after successful renal transplantation Nephrol Dial Transplant 18 2003 1021 1025
32. D. Molino, N.G. De Santo, R. Marotta, P. Anastasio, M. Mosavat, D. De Lucia Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients Semin Nephrol 24 2004 495 501
33. E.J. Lewis, L.G. Hunsicker, S.P. Lan, R.D. Rohde, J.M. Lachin A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group N Engl J Med 326 1992 1373 1379
34. J.E. Balow, H.A. Austin III Maintenance therapy for lupus nephritis - Something old, something new N Engl J Med 350 2004 1044 1046
35. G.H. Stummvoll, M. Aringer, M. Jansen, J.S. Smolen, K. Derfler, W.B. Graninger Immunoadsorption (IAS) as a rescue therapy in SLE Consideration on safety and efficacy Wien Klin Wochenschr 116 2004 716 724
36. G. Contreras, V. Pardo, B. Leclercq Sequential therapies for proliferative lupus nephritis N Engl J Med 350 2004 971 980
37. M. Aringer, J.S. Smolen, W.B. Graninger Severe infections in plasmapheresis-treated systemic lupus erythematosus Arthritis Rheum 41 1998 414 420
38. M.E. Clowse, L.S. Magder, F. Witter, M. Petri The impact of increased lupus activity on obstetric outcomes Arthritis Rheum 52 2005 514 521
39. H.P. McNeil, C.N. Chesterman, S.A. Krilis Immunology and clinical importance of antiphospholipid antibodies Adv Immunol 49 1991 193 280
40. C.A. Clark, K.A. Spitzer, J.N. Nadler, C.A. Laskin Preterm deliveries in women with systemic lupus erythematosus J Rheumatol 30 2003 2127 2132
41. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease Evaluation, classification and stratification Am J Kidney Dis 39 suppl 1 2002 S46 S47